Navigation Links
EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
Date:11/4/2007

bout the prospects for Ceplene's approval, and the application continues to be reviewed according to the expected timetable. We now await the next regulatory milestone, the CHMP's Day 180 Assessment Report and List of Outstanding Issues, which we expect to receive in late November. We will continue to work closely with the EMEA and the CHMP to address any outstanding issues so that the CHMP will be in a position to render a positive opinion."

EpiCept reported progress with several of its key product candidates during the third quarter and subsequent weeks, including:

Ceplene(TM) - a registration-stage compound for the treatment of Acute Myeloid Leukemia (AML), the most common type of leukemia in adults, currently undergoing regulatory review by the European Medicines Agency for the Evaluation of Medicinal Products (EMEA). During the third quarter EpiCept reported that the Marketing Authorization Application (MAA) for Ceplene is advancing according to the anticipated regulatory timetable. The company submitted its full responses to the Day 120 Consolidated List of Questions to the Committee for Human Medicinal Products (CHMP) and EpiCept's staff and consultants met with EMEA officials and CHMP representatives to discuss these responses on September 17, 2007. EpiCept expects to receive the CHMP's Day 180 Assessment Report and List of Outstanding Issues in late November 2007. The company continues to be optimistic about the prospects for approval for this product in the first half 2008. If the application for Ceplene continues to follow usual E.U. regulatory timelines, the likely regulatory milestone for Ceplene following receipt of the Day 180 List of Outstanding Issues will be the option, if required, for EpiCept to attend a Day 181 Oral Explanation with the CHMP to resolve any outstanding issues.

EpiCept NP-1 - a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies, which affect more tha
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. EpiCept Accelerates Development of Phase I Clinical Study for Cancer
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
3. Autopsy reports could be valuable and informative
4. China reports declining number of SARS Cases
5. Russia Reports First SARS Case
6. Research reports that c-section deliveries are rising
7. Jharkhand reports 13,000 Malaria cases
8. Uganda Reports Failure To Contain Sleeping Sickness
9. WHO reports 36 million deaths world wide due to chronic diseases
10. Reports of Hantavirus infection in India raise concerns
11. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... ... assistPoint Partners, LLC is proud to announce a ... Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers together ... and workflow solution. This provides cancer center patient advocates, financial counselors and business ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... Healthy Origins® Cognizin® is a trademark for Citicoline, a nutrient that supports ... capsule for those applications which have more of a semi-solid composition. Vegetarian ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, CA is ... non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands in the ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent studies in ... rise in binge drinking among certain populations and specific locations. Researchers, ... to examine trends and evidence to help facilitate health care treatment to meet ...
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is worth a thousand ... and medical art can be essential. StayWell, a health solutions company, announced today it ... solutions have been used by physicians and other health care providers for more than ...
Breaking Medicine News(10 mins):Health News:assistPoint.com Web Site Launched 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3
... April 18 An ex-White house aide,Robert Weiner, and ... cancer lab, are reporting that many scientists believe that ... a drop in real dollars for,cancer research, and private ... of the federal government." Discoveries are being,lost due to ...
... Coyote goes,hungry in cartoon land, it,s because Roadrunner ... Food Bank wins when nobody goes hungry., ... ), In that spirit, strategic communications firm ... to highlight the tragedy of hunger in New,Mexico ...
... showing the cancer may have an Achilles, heel, report suggests ... Gleevec has forced metastatic melanoma into remission for the first ... , The case involves a 79-year-old woman with melanoma tumors ... an abnormality in a gene called KIT, so the patient ...
... Family Research Council,Action applauds GOP Presidential candidate ... Villanova University supporting the pro-life,platform of the Republican ... of possible running mates., FRC Action,s Senior ... hear Senator McCain depict his support for life ...
... TSTF ), a national provider of healthcare and administrative,staffing ... of Shareholders held on April 17, 2008, at the ... annual meeting, shareholders approved the election of Rick J.,Filippelli ... Directors. In,addition, the Company,s shareholders also approved a proposal ...
... drugs had sharper declines in thinking skills, study finds ... known as anticholinergic drugs -- used to treat ulcers, ... -- may cause older people to lose their thinking ... medicines, new research suggests. , "What we found is ...
Cached Medicine News:Health News:Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers 2Health News:BEEP BEEP!! Strategic Communications Firm DW Turner Thwarts Hunger in Partnership With Roadrunner Food Bank 2Health News:Gleevec Pushes Advanced Melanoma Into Remission 2Health News:FRC Action Praises John McCain's Pro-Life Comments 2Health News:TeamStaff, Inc. Announces Results From Annual Meeting of Shareholders 2Health News:TeamStaff, Inc. Announces Results From Annual Meeting of Shareholders 3Health News:Common Medications May Harm Memory in Older People 2Health News:Common Medications May Harm Memory in Older People 3
(Date:8/4/2015)... , Aug. 04, 2015 ... has announced the addition of the "MRI ... Comfort and Operational Efficiency, with Growth Driven by ... "MRI Systems Market to 2020 - Focus ... Driven by Developing Economies" discusses the market, competitive ...
(Date:8/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... $18.9 million for the three and six months ended ... of $12.1 million and $43.4 million for the same ... driven primarily by the more than $90 million of ... the upfront payment from Bayer to license  ISIS-FXI Rx ...
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 /PRNewswire/ ... announced the addition of Jain PharmaBiotech,s new ... Markets, and Companies" to their offering. ... transdermal drug delivery - an approach used ... therapeutic use as an alternative to oral,intravascular, ...
Breaking Medicine Technology:Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... How Each Tooth Signals the Next to Start GrowingROCHESTER, ... forces determines why mammals develop a single row of ... published today in the journal Science. When completely understood, ... guide efforts to re-grow missing teeth and prevent cleft ...
... preventing bone loss focus on early screening and treatmentLAS ... 75 million baby boomers are approaching the age where ... Osteoporosis ( http://orthoinfo.aaos.org/topic.cfm?topic=A00232 ) also contributes ... United States annually. According to new information presented ...
Cached Medicine Technology:Scientists Discover Why Teeth Form in a Single Row 2Scientists Discover Why Teeth Form in a Single Row 3Scientists Discover Why Teeth Form in a Single Row 4Scientists Discover Why Teeth Form in a Single Row 5Staying One Step Ahead of Osteoporosis 2Staying One Step Ahead of Osteoporosis 3Staying One Step Ahead of Osteoporosis 4
Algerbrush II corneal rust ring remover battery powered...
Katena ophthalmic burr for polishing pterygiums, includes one round diamond burr and has an storage case....
... TW full diameter trial lens set has ... twenty years. While maintaining only the highest ... the Marco 35-6 TW trial lens set ... by adhering to strict industry guidelines, and ...
Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted...
Medicine Products: